Jeffrey Segal serves as Executive at INVO Bioscience, Inc., where they oversee executive responsibilities. Since joining the company, Jeffrey Segal has executed 4 insider transactions totaling $8.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 1, 2022 involved purchasing 9,211 shares valued at $8.8K.
Jeffrey Segal currently holds 28,220 shares of INVO Bioscience, Inc. (INVO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey Segal has been a net buyer of INVO stock. They have purchased $8.8K and sold $0 worth of shares.
Jeffrey Segal's most recent insider trade was on Jun 1, 2022, when they purchased 9,211 shares at $0.95 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 31, 2020 | INVO | $0 | Award | 8,838 | $N/A | Discretionary |
| Nov 27, 2020 | INVO | $0 | Award | 1,137 | $N/A | Discretionary |